Reuters logo
4 months ago
BRIEF-Mdxhealth announces cost-effective results for its SelectMDx test for biopsy selection
April 10, 2017 / 5:14 AM / 4 months ago

BRIEF-Mdxhealth announces cost-effective results for its SelectMDx test for biopsy selection

April 10 (Reuters) - Mdxhealth SA:

* New study shows MDxHealth's SelectMDx test is cost-effective for biopsy selection

* Says its SelectMDx for prostate cancer test can reduce overdiagnosis and overtreatment of men at risk of prostate cancer versus psa testing alone Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below